UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
SCHEDULE 14A INFORMATION

Proxy Statement Pursuant to Section 14(a) of
 
the Securities Exchange Act of 1934
 
Filed by the Registrant   x
Filed by a Party other than the Registrant   o
Check the appropriate box:
o
Preliminary Proxy Statement
o
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
o
Definitive Proxy Statement
x
Definitive Additional Materials
o
Soliciting Material Pursuant to §240.14a-12

 
RAPTOR PHARMACEUTICAL CORP.
(Name of Registrant as Specified In Its Charter)
 
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
 
Payment of Filing Fee (Check the appropriate box):
x
No fee required.
o
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
 
(1)
Title of each class of securities to which transaction applies:
 
 
 
 
(2)
Aggregate number of securities to which transaction applies:
 
 
 
 
(3)
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
 
 
 
 
(4)
Proposed maximum aggregate value of transaction:
 
 
 
 
(5)
Total fee paid:
 
 
 
o
Fee paid previously with preliminary materials.
o
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
 
(1)
Amount Previously Paid:
 
 
 
 
(2)
Form, Schedule or Registration Statement No.:
 
 
 
 
(3)
Filing Party:
 
 
 
 
(4)
Date Filed:
 
 
 
 
 
 


*** Exercise Your Right to Vote ***
Important Notice Regarding the Availability of Proxy Materials for the
Shareholder Meeting to Be Held on July 29, 2014


RAPTOR PHARMACEUTICAL CORP.
Meeting Information
 
Meeting Type:  Annual Meeting
For holders as of:    June 02, 2014
Date:     July 29, 2014     Time:    8:00 AM PST
Location:  Raptor Pharmaceutical Corp.
                   7 Hamilton Landing, Suite 100
                   Novato, CA  94949
 
You are receiving this communication because you hold shares in the above named company.
 
This is not a ballot. You cannot use this notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at www.proxyvote.com or easily request a paper copy (see reverse side).
 
We encourage you to access and review all of the important information contained in the proxy materials before voting.
 
See the reverse side of this notice to obtain proxy materials and voting instructions.
 
 

 
 
 

— Before You Vote —
How to Access the Proxy Materials

Proxy Materials Available to VIEW or RECEIVE:

1.  Notice & Proxy Statement          2.   Annual Report

How to View Online:

Have the information that is printed in the box marked by the arrow
 
à
XXXX XXXX XXXX XXXX
(located on the following page) and visit: www.proxyvote.com.
 
How to Request and Receive a PAPER or E-MAIL Copy:
 
If you want to receive a paper or e-mail copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:
 
1) BY INTERNET:        www.proxyvote.com
 
2) BY TELEPHONE:    1-800-579-1639
 
3) BY E-MAIL*:            sendmaterial@proxyvote.com
 
* If requesting materials by e-mail, please send a blank e-mail with the information that is printed in the box marked by the arrow
à
XXXX XXXX XXXX XXXX
(located on the following page) in the subject line.
 
 
Requests, instructions and other inquiries sent to this e-mail address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before July 15, 2014 to facilitate timely delivery.
 

 
— How To Vote —
 
Please Choose One of the Following Voting Methods
 
Vote In Person:   If you choose to vote these shares in person at the meeting, you must request a "legal proxy." To do so, please follow the instructions at www.proxyvote.com or request a paper copy of the materials, which will contain the appropriate instructions. Many shareholder meetings have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance.
 

Vote By Internet: To vote now by Internet, go to www.proxyvote.com. Have the information that is printed in the box marked by the arrow
à
XXXX XXXX XXXX XXXX
available and follow the instructions.
 
 
Vote By Mail: You can vote by mail by requesting a paper copy of the materials, which will include a voting instruction form.
 
 
 

Voting Items:

The Board of Directors recommends you vote FOR the following proposal(s):

1.
Election of Directors
 
Nominees:
 
01     Raymond W. Anderson
 
02     Suzanne L. Bruhn
 
03     Richard L. Franklin
 
04     Llew Keltner
 
05     Erich Sager
 
06     Vijay B. Samant
 
07     Christopher M. Starr
 
08     Timothy P. Walbert

The Board of Directors recommends you vote FOR the following proposal(s):

2.
  To approve, on an advisory basis, the compensation of the Company's Named Executive Officers.


3.
To ratify the appointment by the audit committee of the Board of Directors of Grant Thornton LLP. as Raptor's independent registered public accounting firm for the year ending December 31, 2014.


4.
To approve the Raptor Pharmaceutical Corp. 2013 Employee Stock Purchase Plan.


Voting items Continued



 
NOTE: Such other business as may properly come before the meeting or any adjournment thereof.
 
 



Voting Instructions